Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Erector Spinae Plane Block in Radical Cystectomy [NA]
A completed clinical trial from Kafrelsheikh University evaluating erector spinae plane block for patients undergoing radical cystectomy; th…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer [NA]
The document discusses a clinical trial comparing mpMRI to diagnostic TURBT for suspected muscle-invasive bladder cancer and notes that recr…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) [NA]
This clinical trial update describes PreAct, a study evaluating whether preoperative physical activity can be improved by using activity tra…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating ALT-801 in combination with cisplatin and gemcitabine in patients with muscle-…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Robot-assisted Function-sparing Cystectomy Followed by Modified Orthotopic Ileal Neobladder [NA]
This clinical trial update describes robot-assisted function-sparing cystectomy followed by modified orthotopic ileal neobladder, with recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-10FDA Approved: CISPLATIN — Original Application (Apotex Corp.)
FDA approved the original application for cisplatin from Apotex Corp., enabling the generic version to be marketed in the United States.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia [NA]
A clinical trial update for organ-preserving therapy of bladder cancer using radiotherapy or radiochemotherapy with hyperthermia; currently …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: 3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical Cystectomy [NA]
Completed clinical trial evaluating three ultrasound-guided plane blocks for perioperative analgesia in patients undergoing radical cystecto…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy [NA]
This clinical trial update reports completion of a study evaluating optimized perioperative antibiotic prophylaxis in radical cystectomy to …
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
A clinical trial evaluating the prognostic performance of a chemogram in patients with bladder cancer, currently recruiting.
-
CLINICAL_TRIALS other · 2024-05-01Clinical Trial Update: The Man Van Project [NA]
The Man Van Project clinical trial, sponsored by Royal Marsden NHS Foundation Trust, is currently recruiting for prostate cancer and related…
-
CLINICAL_TRIALS withdrawal · 2024-04-24Clinical Trial Update: A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial [Phase 3]
A Phase 3 randomized trial evaluating 2% lidocaine injection for male rigid cystoscopy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy [Phase 3]
A Phase 3 randomized trial comparing standard versus goal-directed perioperative fluid management for patients undergoing radical cystectomy…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC [Phase 2]
Phase 2 trial evaluating checkpoint inhibition with chemoradiotherapy as a bladder-sparing approach for urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for intravenous vitamin C combined with chemotherapy in cisplatin-ineligible bladder ca…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer [Phase 2]
Phase 2 trial update evaluating ICP-192 for efficacy and safety in bladder urothelial cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study [Phase 2]
Phase 2 trial evaluating avelumab as a single agent in metastatic or locally advanced urothelial cancer in patients unfit for cisplatin has …
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial assessing acupuncture for treating adverse events related to intravesical BCG in high-risk non-muscle invasive bladde…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Radiogenomics of Muscle Invasive Bladder Cancer [NA]
A terminated clinical trial study on radiogenomics in muscle invasive bladder cancer was conducted; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies [Phase 1, Phase 2]
A dose-finding and safety study of an oral single-agent therapy for advanced solid tumors, including metastatic bladder cancer, completed wi…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol [Phase 3]
Phase 3 clinical trial comparing alvimopan to placebo in bladder cancer patients undergoing radical cystectomy under an enhanced recovery pr…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of Pseudomonas aeruginosa for intermediate and high-risk non-muscle invasive bl…
-
FDA approval · 2023-09-19FDA Approved: DOCETAXEL — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal's supplemental application to manufacture and market a generic docetaxel, enabling its supply for cancer treatment i…